Market Cap 25.75M
Revenue (ttm) 0.00
Net Income (ttm) -15.01M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 137,700
Avg Vol 662,140
Day's Range N/A - N/A
Shares Out 24.29M
Stochastic %K 71%
Beta 0.90
Analysts Strong Sell
Price Target $10.00

Company Profile

Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra (ENX-CL-02-002), which is in phase II clinical trial for the treatment of organ dysfunction and failure caused by sepsis; and Allocetra (ENX-CL-05-001), which is in phase I/II clinical trial to treat moderate knee osteoarthritis. The company also develops 0189-22-KMC, which is in phase I/II clinical trial to treat...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 2 620 8072
Address:
14 Einstein Street, Ness Ziona, Israel
Beebee12
Beebee12 Oct. 3 at 8:16 PM
$ENLV thinking about buying some. Anyone have a price guess here?? Thanks
0 · Reply
GaryGherkins
GaryGherkins Oct. 2 at 1:29 PM
$ENLV was seriously considering an investment here but have had really bad luck with israeli companies in the past. they have a tendency to make a pile of sht sound like your investing in a pile of gold. lost money in every single trade.
1 · Reply
highnihilism
highnihilism Oct. 1 at 10:18 AM
$ENLV Enlivex Therapeutics Trade Count: 10 | Total $: 1.9 K | 0.26 × 90-Day Avg $: 7.2 K | Call $: 1.9 K | Put $: 0 | % Single-Leg: 96% | % Multi-Leg: 4% | % Contingent: – $YMAG Yieldmax Magnificent 7 Option Income ETF Trade Count: 17 | Total $: 2.7 K | 0.29 × 90-Day Avg $: 9.3 K | Call $: 1.9 K | Put $: 817 | % Single-Leg: 92% | % Multi-Leg: 8% | % Contingent: – $TRU Transunion Trade Count: 22 | Total $: 5.2 K | 0.01 × 90-Day Avg $: 359.4 K | Call $: 1.9 K | Put $: 3.4 K | % Single-Leg: 77% | % Multi-Leg: 23% | % Contingent: – $FIBK First Interstate Bancsystem Trade Count: 4 | Total $: 2.6 K | 0.37 × 90-Day Avg $: 7 K | Call $: 1.9 K | Put $: 780 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
THEJSAENZ
THEJSAENZ Sep. 30 at 7:48 PM
$ENLV pr from todays webinar would be awesome.
2 · Reply
Beebee12
Beebee12 Sep. 30 at 7:11 PM
$ENLV anybody target here?
0 · Reply
JarvisFlow
JarvisFlow Sep. 26 at 11:29 AM
D. Boral Capital updates rating for Enlivex Therapeutics ( $ENLV ) to Buy, target set at 13.
0 · Reply
Rybod30
Rybod30 Sep. 25 at 11:57 AM
$ENLV $2 looks to be tested today. Frustrating hold here, sell a drone to somebody?!?
1 · Reply
highnihilism
highnihilism Sep. 24 at 2:40 PM
Market cap ≤ $500M (Biotech) $CLGN CollPlant Biotechnologies $ENLV Enlivex Therapeutics $HILS Hillstream BioPharma $ONTX Onconova Therapeutics $VERU Veru
0 · Reply
tsj555
tsj555 Sep. 21 at 4:29 AM
$ENLV 💩
0 · Reply
BaridBanger
BaridBanger Sep. 19 at 7:31 PM
$ENLV this will make a move soon
0 · Reply
Latest News on ENLV
Enlivex Selected to Present at Israeli BioMed 2025 Conference

May 20, 2025, 8:00 AM EDT - 4 months ago

Enlivex Selected to Present at Israeli BioMed 2025 Conference


Enlivex Issues Urgent Statement on Fraudulent News Dissemination

Feb 18, 2025, 6:20 AM EST - 8 months ago

Enlivex Issues Urgent Statement on Fraudulent News Dissemination


Enlivex Appoints Andrew Singer to its Board of Directors

Apr 17, 2023, 8:00 AM EDT - 2 years ago

Enlivex Appoints Andrew Singer to its Board of Directors


Beebee12
Beebee12 Oct. 3 at 8:16 PM
$ENLV thinking about buying some. Anyone have a price guess here?? Thanks
0 · Reply
GaryGherkins
GaryGherkins Oct. 2 at 1:29 PM
$ENLV was seriously considering an investment here but have had really bad luck with israeli companies in the past. they have a tendency to make a pile of sht sound like your investing in a pile of gold. lost money in every single trade.
1 · Reply
highnihilism
highnihilism Oct. 1 at 10:18 AM
$ENLV Enlivex Therapeutics Trade Count: 10 | Total $: 1.9 K | 0.26 × 90-Day Avg $: 7.2 K | Call $: 1.9 K | Put $: 0 | % Single-Leg: 96% | % Multi-Leg: 4% | % Contingent: – $YMAG Yieldmax Magnificent 7 Option Income ETF Trade Count: 17 | Total $: 2.7 K | 0.29 × 90-Day Avg $: 9.3 K | Call $: 1.9 K | Put $: 817 | % Single-Leg: 92% | % Multi-Leg: 8% | % Contingent: – $TRU Transunion Trade Count: 22 | Total $: 5.2 K | 0.01 × 90-Day Avg $: 359.4 K | Call $: 1.9 K | Put $: 3.4 K | % Single-Leg: 77% | % Multi-Leg: 23% | % Contingent: – $FIBK First Interstate Bancsystem Trade Count: 4 | Total $: 2.6 K | 0.37 × 90-Day Avg $: 7 K | Call $: 1.9 K | Put $: 780 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: –
0 · Reply
THEJSAENZ
THEJSAENZ Sep. 30 at 7:48 PM
$ENLV pr from todays webinar would be awesome.
2 · Reply
Beebee12
Beebee12 Sep. 30 at 7:11 PM
$ENLV anybody target here?
0 · Reply
JarvisFlow
JarvisFlow Sep. 26 at 11:29 AM
D. Boral Capital updates rating for Enlivex Therapeutics ( $ENLV ) to Buy, target set at 13.
0 · Reply
Rybod30
Rybod30 Sep. 25 at 11:57 AM
$ENLV $2 looks to be tested today. Frustrating hold here, sell a drone to somebody?!?
1 · Reply
highnihilism
highnihilism Sep. 24 at 2:40 PM
Market cap ≤ $500M (Biotech) $CLGN CollPlant Biotechnologies $ENLV Enlivex Therapeutics $HILS Hillstream BioPharma $ONTX Onconova Therapeutics $VERU Veru
0 · Reply
tsj555
tsj555 Sep. 21 at 4:29 AM
$ENLV 💩
0 · Reply
BaridBanger
BaridBanger Sep. 19 at 7:31 PM
$ENLV this will make a move soon
0 · Reply
kellymone2
kellymone2 Sep. 18 at 3:25 PM
$ENLV massively undervalued. For me it's a 6$ stock at least
0 · Reply
Mrsdelbusto1
Mrsdelbusto1 Sep. 18 at 12:48 PM
0 · Reply
BULLTRADER0007
BULLTRADER0007 Sep. 17 at 10:46 PM
$ENLV about to take off to the moon, pay attention
1 · Reply
BioTechHealthX
BioTechHealthX Sep. 16 at 8:12 AM
$ENLV Enlivex narrowed its Q2 net loss to $1.87M from $3.1M last year, reducing burn as Allocetra delivers strong clinical wins. https://biotechhealthx.com/biotech-news/enlivex-enlv-reports-1-87m-q2-loss-cuts-cash-burn-nearly-40/
0 · Reply
Stellabella50
Stellabella50 Sep. 15 at 2:26 PM
$ENLV while this is deciding what it wants to do, $WRD is making some nice moves.
0 · Reply
DARKP00L
DARKP00L Sep. 12 at 12:22 PM
$ENLV 08:00 on Sep. 12 2025 D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target #tradeideas
2 · Reply
JarvisFlow
JarvisFlow Sep. 12 at 12:00 PM
D. Boral Capital updates rating for Enlivex Therapeutics ( $ENLV ) to Buy, target set at 13.
0 · Reply
Lisamh76
Lisamh76 Sep. 10 at 5:36 PM
$ENLV I thought they were overestimating this at 7-10, most being around a $7 PT, but based on latest analysis with potential in the industry (and make no mistake, ENLV is showing the data to be a beast) a new forecast is even as high as $13! this is on the horizon, and i strongly recommend this to easily 5x your dough minimum in the next year! All honesty, i still dont see over 5 pps based on potential customer base and industry valuation. https://www.nasdaq.com/articles/new-analyst-forecast-enlv-given-130-price-target
0 · Reply
kellymone2
kellymone2 Sep. 10 at 7:12 AM
0 · Reply
JJRADANO
JJRADANO Sep. 9 at 10:50 PM
$ENLV Doesn't Enlv have some type of investment or cash management strategy with Bitcoin?
2 · Reply
jacksonjohn750
jacksonjohn750 Sep. 9 at 7:45 PM
$ENLV time to load if you need a write off this Dec
0 · Reply
DARKP00L
DARKP00L Sep. 9 at 12:03 PM
$ENLV 08:03 on Sep. 09 2025 Enlivex Secures Israeli Patent For Allocetra In Osteoarthritis Treatment, Extending IP Protection Through 2040 #tradeideas
2 · Reply